| ?? |
?? ?? |
CAS |
MF |
 |
????? |
30233-64-8 |
C25H50O4 |
 |
4,4'-((2S,2'S,4S,4'S)-((methylenebis(5-methoxy-7-methyl-1H-indole-3,4-diyl))bis(methylene))bis(4-ethoxypiperidine-1,2-diyl))dibenzoic acid |
|
|
 |
Dehydrocarteolol Hydrochloride |
62330-84-1 |
C16H22N2O3 |
 |
951313-25-0 |
951313-25-0 |
C25H33N3O6 |
 |
????? |
378746-64-6 |
C20H25N3O4 |
 |
951163-66-9 |
951163-66-9 |
C18H17BFNO8 |
 |
??3-(2,4-?????-3-?????)-3-????????? |
221221-12-1 |
C12H12F2O4 |
 |
Tocopherol Impurity 1 |
3808-26-2 |
C29H48O2 |
![N-formyl-1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide](/CAS/20180703/GIF/1351611-14-7.gif) |
N-formyl-1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide |
1351611-14-7 |
C26H25N5O5 |
 |
Ibrexafungerp intermediates |
1207755-36-9 |
C52H77NO7S |
 |
(1S,2R)-2-(((2,4-dimethylpyrimidin-5-yl)oxy)methyl)-2-(3-fluorophenyl)-N-(5-fluoropyridin-2-yl)cyclopropanecarboxamide |
|
|
 |
tert-butyl (2-methoxy-6-nitro-4-(4-oxopiperidin-1-yl)phenyl)carbamate |
|
|
![Methanone, [(2S)-2-(6-chloro-7-methyl-1H-benzimidazol-2-yl)-2-methyl-1-pyrrolidinyl][5-hydroxy-2-(2H-1,2,3-triazol-2-yl)phenyl]-](/CAS/20210305/GIF/2901043-05-6.gif) |
Methanone, [(2S)-2-(6-chloro-7-methyl-1H-benzimidazol-2-yl)-2-methyl-1-pyrrolidinyl][5-hydroxy-2-(2H-1,2,3-triazol-2-yl)phenyl]- |
2901043-05-6 |
C22H21ClN6O2 |
 |
LANTHANUM STANDARD SOLUTION |
|
La |
 |
5,9,13,17-Nonadecatetraen-2-one, 6,10,14,18-tetramethyl-, (Z,E,Z)- (8CI) |
3879-25-2 |
C23H38O |
 |
N-(4-methoxy-5-((3-((4-methoxy-2-(4-(3-methoxyazetidin-1-yl)piperidin-1-yl)-5-((6-(1-methyl-1H-indazol-5-yl)pyrimidin-4-yl)amino)phenyl)amino)-3-oxopropyl)amino)-2-(4-(3-methoxyazetidin-1-yl)piperidin-1-yl)phenyl)acrylamide |
|
|
 |
N-(4-methoxy-2-(4-(3-methoxyazetidin-1-yl)piperidin-1-yl)-5-((6-(1-methyl-1H-indazol-5-yl)pyrimidin-4-yl)amino)phenyl)-N-(3-((4-methoxy-2-(4-(3-methoxyazetidin-1-yl)piperidin-1-yl)-5-((6-(1-methyl-1H-indazol-5-yl)pyrimidin-4-yl)amino)phenyl)amino)-3-oxopropyl)acrylamide |
|
|
![Methanone, [5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl][(2S)-2-methyl-2-(7-methyl-1H-benzimidazol-2-yl)-1-pyrrolidinyl]-](/CAS/20210305/GIF/1505484-96-7.gif) |
Methanone, [5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl][(2S)-2-methyl-2-(7-methyl-1H-benzimidazol-2-yl)-1-pyrrolidinyl]- |
1505484-96-7 |
C23H24N6O2 |
![5H-Pyrazolo[4,3-c]pyridine-5-carboxylic acid, 3-amino-2-(4-chloro-3,5-dimethylphenyl)-2,4,6,7-tetrahydro-4-methyl-, 1,1-dimethylethyl ester, (4S)-](/CAS/20210305/GIF/2212021-92-4.gif) |
5H-Pyrazolo[4,3-c]pyridine-5-carboxylic acid, 3-amino-2-(4-chloro-3,5-dimethylphenyl)-2,4,6,7-tetrahydro-4-methyl-, 1,1-dimethylethyl ester, (4S)- |
2212021-92-4 |
C20H27ClN4O2 |
 |
N-???????? |
78249-62-4 |
C7H18N4O |
 |
Biapenem Impurity B |
|
|
 |
LS01-I09 |
|
|
![(R)-(2-(6-chloro-7-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone](/) |
(R)-(2-(6-chloro-7-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone |
|
|
 |
Ferrous tartrate solution c(FeSO4)=1 g/L,c(C4H4O6KNa)=5 g/L |
|
|
![N-[2-(acetyloxy)propyl]-N-[3-[4-(1,1-diMethylpropyl)phenyl]-2-Methylpropyl]-forMaMide](/CAS/20150408/GIF/142347-84-0.gif) |
N-[2-(acetyloxy)propyl]-N-[3-[4-(1,1-diMethylpropyl)phenyl]-2-Methylpropyl]-forMaMide |
142347-84-0 |
C21H33NO3 |
 |
3-(methyl-d3)pyridin-4,5,6-d3-2-amine |
2247346-23-0 |
C6H2D6N2 |
 |
Edoxaban Impurity 29 |
2244103-96-4 |
C24H30ClN7O5S |
 |
Aciclovir Impurity 7 |
|
|
![Butanoic acid, 2-[3-[[2-benzoxazolyl[3-(4-hydroxyphenoxy)propyl]amino]methyl]phenoxy]-](/CAS/20210305/GIF/848260-34-4.gif) |
Butanoic acid, 2-[3-[[2-benzoxazolyl[3-(4-hydroxyphenoxy)propyl]amino]methyl]phenoxy]- |
848260-34-4 |
C27H28N2O6 |
 |
Reference Material for the Calibration of Urine Analyzer |
|
|
 |
Atropine Impurity 4 |
3423-23-2 |
C17H23NO3 |
 |
N-nitroso-desmethyl-Clemastine |
|
|
 |
Spectinomycin EP Impurity C |
63393-23-7 |
C14H26N2O7 |
 |
(4-hydroxy-1-(hydroxymethyl)-7-phenoxyisoquinoline-3-carbonyl)glycine |
|
|
![[1,1'-Biphenyl]-3,3'-dicarboxamide, 6,6'-diamino-5-chloro-N3,N3'-bis[2-(diethylamino)ethyl]-2,4'-dimethoxy-](/CAS/20210305/GIF/1242047-99-9.gif) |
[1,1'-Biphenyl]-3,3'-dicarboxamide, 6,6'-diamino-5-chloro-N3,N3'-bis[2-(diethylamino)ethyl]-2,4'-dimethoxy- |
1242047-99-9 |
C28H43ClN6O4 |
![1H-Benzimidazole, 6-chloro-7-methyl-2-[(2S)-2-methyl-2-pyrrolidinyl]-](/CAS/20210305/GIF/1788946-71-3.gif) |
1H-Benzimidazole, 6-chloro-7-methyl-2-[(2S)-2-methyl-2-pyrrolidinyl]- |
1788946-71-3 |
C13H16ClN3 |
 |
(R)-2-(3-(((3-(4-methoxyphenoxy)propyl)amino)methyl)phenoxy)butanoic acid |
|
|
![(S)-6-chloro-7-methyl-2-(2-methyl-1-nitrosopyrrolidin-2-yl)-1H-benzo[d]imidazole](/CAS/20250703/GIF/3112735-67-5.gif) |
(S)-6-chloro-7-methyl-2-(2-methyl-1-nitrosopyrrolidin-2-yl)-1H-benzo[d]imidazole |
3112735-67-5 |
C13H15ClN4O |
 |
2-Hydroxy-3-(pyridin-3-yl)pyridine |
82407-65-6 |
C10H8N2O |
![2,8-Chrysenedione, 10b-fluoro-1,3,4,4a,4b,5,6,10a,10b,11,12,12a-dodecahydro-1,11-dihydroxy-3,10a,12a-trimethyl-1-[(phosphonooxy)methyl]-, (1S,3S,4aS,4bS,10aS,10bR,11S,12aS)-](/CAS/20210111/GIF/1202002-01-4.gif) |
2,8-Chrysenedione, 10b-fluoro-1,3,4,4a,4b,5,6,10a,10b,11,12,12a-dodecahydro-1,11-dihydroxy-3,10a,12a-trimethyl-1-[(phosphonooxy)methyl]-, (1S,3S,4aS,4bS,10aS,10bR,11S,12aS)- |
1202002-01-4 |
C22H30FO8P |
![Carbonic acid, (12aR)-12-[(11S)-7,8-difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-yl]-3,4,6,8,12,12a-hexahydro-6,8-dioxo-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazin-7-yl methyl ester](/CAS/20210305/GIF/1985606-48-1.gif) |
Carbonic acid, (12aR)-12-[(11S)-7,8-difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-yl]-3,4,6,8,12,12a-hexahydro-6,8-dioxo-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazin-7-yl methyl ester |
1985606-48-1 |
C26H21F2N3O6S |
 |
???????????? |
100843-69-4 |
|
![2-Naphthalenamine, N-(diphenylmethylene)-6-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5-[2-[tris(1-methylethyl)silyl]ethynyl]-](/CAS/20210305/GIF/2816821-08-4.gif) |
2-Naphthalenamine, N-(diphenylmethylene)-6-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5-[2-[tris(1-methylethyl)silyl]ethynyl]- |
2816821-08-4 |
C40H47BFNO2Si |
 |
((2S,5R)-2-carbamoyl-5-((sulfooxy)amino)piperidine-1-carbonyl)-L-arginine |
|
|
 |
(1R,3aR,7aR)-7a-Methyl-1-((R)-6-Methylheptan-2-yl)hexahydro-1H-inden-4(2H)-one |
66251-18-1 |
C18H32O |
 |
???????(R)-???? |
864070-43-9 |
C23H27ClO7 |
 |
Fructus Xanthii |
|
|
 |
2,2'-BIPYRIDIN-6-OL |
101001-90-5 |
C10H8N2O |
![Spiro[4H-3,1-benzoxazine-4,7'(6'H)-pyrrolo[1,2-a]pyrazine]-1',2,4'(1H)-trione, 6'-(1,3-benzodioxol-5-yl)-2',3',8',8'a-tetrahydro-2'-methyl-, (8'aR)-](/CAS/20210305/GIF/2747958-44-5.gif) |
Spiro[4H-3,1-benzoxazine-4,7'(6'H)-pyrrolo[1,2-a]pyrazine]-1',2,4'(1H)-trione, 6'-(1,3-benzodioxol-5-yl)-2',3',8',8'a-tetrahydro-2'-methyl-, (8'aR)- |
2747958-44-5 |
C22H19N3O6 |
 |
HERBA PLANTAGINIS |
|
|
 |
?? |
16984-48-8 |
F- |
 |
Aztreonam USP Impurity B |
|
|
 |
Mirogabalin Impurity N84 |
2166206-19-3 |
C12H19NO2 |
 |
LS01-I01 |
|
|
 |
2-(1-METHYL-5-NITRO-1H-IMIDAZOL-2-YL)-PROPAN-2-OL |
35175-14-5 |
C7H11N3O3 |
 |
NIVALENOL |
23282-20-4 |
C15H20O7 |
 |
3-ACETYLDEOXYNIVALENOL |
50722-38-8 |
C17H22O7 |
 |
BENFLUOREX HYDROCHLORIDE |
23602-78-0 |
C19H20F3NO2 |
 |
RETRORSINE |
480-54-6 |
C18H25NO6 |
 |
DIACETOXYSCIRPENOL |
2270-40-8 |
C19H26O7 |
 |
Thiamine EP Impurity F HCl |
4102-72-1 |
C13H19N4OS.ClH.Cl |
 |
ZEARALANONE |
5975-78-0 |
C18H24O5 |
 |
5-BENZYL-3,6-DIOXO-2-PIPERAZINEACETIC ACID |
5262-10-2 |
C13H14N2O4 |
 |
OCHRATOXIN B |
4825-86-9 |
C20H19NO6 |
 |
??? ?? ??? |
171869-95-7 |
C21H24ClNO5 |
 |
?????????-2,4-DNPH ??? |
2256-01-1 |
C11H14N4O4 |
 |
???? |
492-80-8 |
C17H21N3 |
 |
??? |
479-45-8 |
C7H5N5O8 |
 |
6,8-????????? |
462-20-4 |
C8H16O2S2 |
 |
??????? |
84332-86-5 |
C13H11Cl2NO5 |
 |
????????(RING-D4) |
93951-89-4 |
C10H10O4 |
 |
2,2',4,4',5,6'-HEXABROMODIPHENYL ETHER |
207122-15-4 |
C12H4Br6O |
 |
N-??????-N-???-2,5-????-3-???? |
60568-05-0 |
C14H21NO3 |
 |
DI-N-PROPYL PHTHALATE-3,4,5,6-D4 |
358731-29-0 |
C14H18O4 |
 |
DEHYDROANDROGRAPHOLIDESUCCINATE |
786593-06-4 |
C28H36O10 |
 |
DI-ISO-BUTYL PHTHALATE-3,4,5,6-D4 |
358730-88-8 |
C16H18D4O4 |
 |
15-ACETOXY-3ALPHA,7ALPHA-DIHYDROXY-12,13-EPOXYTRICHOTHEC-9-EN-8-ONE |
88337-96-6 |
C17H22O7 |
 |
2-Hydroxy-5-(4-pyridyl)pyridine |
62749-34-2 |
C10H8N2O |
 |
???? (COM?RCIAL) |
12789-03-6 |
C10H6Cl8 |
 |
SILYBIN (MIXTURE OF SILYBIN A AND SILYBIN B) |
36804-17-8 |
C25H22O10 |
 |
3-AMINO-5-MORPHOLINOMETHYL-2-OXAZOLIDINONE |
43056-63-9 |
C8H15N3O3 |
 |
2-Hydroxy-5-(3-pyridyl)pyridine |
1111109-65-9 |
C10H8N2O |
 |
???????????? |
121-82-4 |
C3H6N6O6 |
 |
Hydroxymetronidazole |
4812-40-2 |
C6H9N3O4 |
 |
METHYL OCTACOSANOATE |
55682-92-3 |
C29H58O2 |
 |
CIS-4,7,10,13,16,19-DOCOSAHEXAENOIC ACID METHYL ESTER |
301-01-9 |
C23H34O2 |
 |
THEAFLAVINE-3,3'-DIGALLATE |
33377-72-9 |
C43H32O20 |
 |
TRICLOSAN METHYL ETHER |
4640-01-1 |
C13H9Cl3O2 |
 |
OXADIARGYL PESTANAL |
39807-15-3 |
C15H14Cl2N2O3 |
 |
BETA-ZEARALENOL |
71030-11-0 |
C18H24O5 |
 |
??(J)????? |
205-82-3 |
C20H12 |
 |
2,5-DIMETHYLBENZALDEHYDE (DNPH DERIVATIVE) |
152477-96-8 |
C15H14N4O4 |
 |
ZERANOL |
55331-29-8 |
C18H26O5 |
 |
TETRADECANOIC-D27 ACID |
60658-41-5 |
C14HD27O2 |
 |
ALPHA-ZEARALENOL |
36455-72-8 |
C18H24O5 |
 |
2,2',4,4'-TETRABROMODIPHENYL ETHER |
5436-43-1 |
C12H6Br4O |
 |
cucurbitacins |
60137-06-6 |
C30H42O6 |
 |
DODECANOIC-D23 ACID |
59154-43-7 |
C12HD23O2 |
![4-[2-(DIMETHYLAMINO)ETHYLAMINOSULFONYL]-7-CHLORO-2,1,3-BENZOXADIAZOLE](/CAS/GIF/664985-43-7.gif) |
4-[2-(DIMETHYLAMINO)ETHYLAMINOSULFONYL]-7-CHLORO-2,1,3-BENZOXADIAZOLE |
664985-43-7 |
C10H13ClN4O3S |
 |
HT-2 TOXIN |
26934-87-2 |
C22H32O8 |